Replimune Limited
Research and experimental development on biotechnology · Abingdon
ActiveUnited KingdomIncorporated 2015Private Limited Company
Financial position
Accounts to 2026-03-31 · USD · company scope
Net assets
USD 10,874,053
Cash
USD 4,439,720
Turnover
—
Profit / loss
−USD 247,674,374
Current assets
USD 8,593,216
Creditors < 1 year
−USD 28,163,219
Equity
−USD 18,311,674
Average employees
79
Balance-sheet trend
USD · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2026-03-31USD · company | 2025-03-31USD · company | 2024-03-31USD · company | 2023-03-31USD · company | 2022-03-31USD · unknown | 2021-03-31USD · unknown | 2020-03-31GBP · unknown | 2019-03-31GBP · unknown | 2018-03-31GBP · unknown | 2017-03-31GBP · unknown | 2016-03-31GBP · unknown | 2016-02-29GBP · unknown |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet | ||||||||||||
| Net assets | USD 10,874,053 | USD 9,958,411 | −USD 75,210,152 | −USD 26,352,439 | — | — | — | £5,341,686 | — | — | £10,751,914 | — |
| Equity | −USD 18,311,674 | −USD 34,943,259 | −USD 75,210,152 | −USD 26,352,439 | −USD 12,660,392 | −USD 1,662,725 | −£9,273,863 | £1,411,785 | £11,547,827 | £19,587,895 | £10,555,214 | £10,555,214 |
| Assets | ||||||||||||
| Fixed assets | USD 2,280,837 | USD 2,731,378 | — | — | — | — | — | — | — | — | £115,609 | — |
| Property, plant & equipment | USD 2,280,837 | USD 2,731,378 | — | — | — | — | — | £352,454 | — | — | £115,608 | — |
| Current assets | USD 8,593,216 | USD 7,227,033 | — | — | — | — | — | £4,989,232 | — | — | £10,636,305 | — |
| Cash at bank | USD 4,439,720 | USD 2,393,424 | — | — | — | — | — | £2,706,601 | — | — | £9,691,749 | — |
| Debtors | USD 792,569 | USD 1,108,629 | — | — | — | — | — | £382,757 | — | — | £743,577 | — |
| Liabilities | ||||||||||||
| Creditors within one year | −USD 28,163,219 | −USD 43,624,655 | — | — | — | — | — | −£3,929,901 | — | — | −£196,700 | — |
| Net current assets | USD 28,163,219 | USD 43,624,655 | — | — | — | — | — | £3,929,901 | — | — | £196,700 | — |
| Assets less current liabilities | USD 29,185,727 | USD 44,901,670 | — | — | — | — | — | £3,929,901 | — | — | £196,700 | — |
| Profit & loss | ||||||||||||
| Operating profit | −USD 249,105,057 | −USD 216,256,326 | — | — | — | — | — | −£18,950,008 | — | — | −£689,804 | — |
| Profit before tax | −USD 249,278,562 | −USD 216,465,950 | — | — | — | — | — | −£18,895,415 | — | — | −£679,377 | — |
| Profit / loss | −USD 247,674,374 | −USD 214,693,315 | — | — | — | — | — | −£16,995,541 | — | — | −£478,398 | — |
| People | ||||||||||||
| Average employees | 79 | 68 | — | — | — | — | — | 32 | — | — | 3 | — |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
4 outstanding chargesFloating · created 2026-01-29
—
OutstandingFixed · created 2024-02-27
—
OutstandingFixed · created 2022-10-06
—
OutstandingAll Assets · created 2022-10-06
—
OutstandingShow 2 satisfied / released
All Assets · created 2019-08-07 · satisfied 2022-09-27
—
SatisfiedFixed · created 2015-10-30 · satisfied 2018-07-22
—
Satisfied